In cancer, CXCL16 exerts paradoxical roles: via CXCR6 activation, it fuels tumor proliferation, invasion, and VEGF/MMP-driven angiogenesis, yet orchestrates antitumor immunity by recruiting NKT cells. The gene discussed is CXCR6; the disease is neoplasm.